Trial Profile
A 6-Week Prospective, Open-Label, Multicenter Study of Aripiprazole Augmentation for Patients With major Depressive Disorders who have an Inadequate Response to Antidepressant Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 21 May 2014 New trial record